Literature DB >> 18209095

Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.

Thomas J Scriba1, Barbara Kalsdorf, Deborah-Ann Abrahams, Fatima Isaacs, Jessica Hofmeister, Gillian Black, Hisham Y Hassan, Robert J Wilkinson, Gerhard Walzl, Sebastian J Gelderbloem, Hassan Mahomed, Gregory D Hussey, Willem A Hanekom.   

Abstract

We investigated whether the proinflammatory T cell cytokines IL-17 and IL-22 are induced by human mycobacterial infection. Remarkably, >20% of specific cytokine-producing CD4(+) T cells in peripheral blood of healthy, mycobacteria-exposed adults expressed IL-17 or IL-22. Specific IL-17- and IL-22-producing CD4(+) T cells were distinct from each other and from Th1 cytokine-producing cells. These cells had phenotypic characteristics of long-lived central memory cells. In patients with tuberculosis disease, peripheral blood frequencies of these cells were reduced, whereas bronchoalveolar lavage fluid contained higher levels of IL-22 protein compared with healthy controls. IL-17 was not detected in this fluid, which may be due to suppression by Th1 cytokines, as PBMC IL-17 production was inhibited by IFN-gamma in vitro. However, Th1 cytokines had no effect on IL-22 production in vitro. Our results imply that the magnitude and complexity of the anti-mycobacterial immune response have historically been underestimated. IL-17- and IL-22-producing CD4(+) T cells may play important roles in the human immune response to mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209095      PMCID: PMC2219462          DOI: 10.4049/jimmunol.180.3.1962

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

Authors:  S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27.

Authors:  Ruth D Fritsch; Xinglei Shen; Gary P Sims; Karen S Hathcock; Richard J Hodes; Peter E Lipsky
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

3.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

6.  Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls.

Authors:  A Lenarczyk; J Helsloot; K Farmer; L Peters; A Sturgess; B Kirkham
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

8.  Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.

Authors:  P Ye; P B Garvey; P Zhang; S Nelson; G Bagby; W R Summer; P Schwarzenberger; J E Shellito; J K Kolls
Journal:  Am J Respir Cell Mol Biol       Date:  2001-09       Impact factor: 6.914

9.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies.

Authors:  Willem A Hanekom; Jane Hughes; Maushumi Mavinkurve; Megan Mendillo; Marcia Watkins; Hoyam Gamieldien; Sebastian J Gelderbloem; Mzwandile Sidibana; Nazma Mansoor; Virginia Davids; Rose Ann Murray; Anthony Hawkridge; Patrick A J Haslett; Stanley Ress; Gregory D Hussey; Gilla Kaplan
Journal:  J Immunol Methods       Date:  2004-08       Impact factor: 2.303

View more
  193 in total

1.  Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells.

Authors:  Gucheng Zeng; Crystal Y Chen; Dan Huang; Shuyu Yao; Richard C Wang; Zheng W Chen
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant.

Authors:  Anna U Bielinska; Michele Gerber; Luz P Blanco; Paul E Makidon; Katarzyna W Janczak; Michael Beer; Benjamin Swanson; James R Baker
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 3.  Th17 cytokines and vaccine-induced immunity.

Authors:  Yinyao Lin; Samantha R Slight; Shabaana A Khader
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

4.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

5.  Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

Authors:  N Pavan Kumar; R Anuradha; R Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2011-09-28

Review 6.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

7.  The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.

Authors:  Léanie Kleynhans; Nelita Du Plessis; Nasiema Allie; Muazzam Jacobs; Martin Kidd; Paul D van Helden; Gerhard Walzl; Katharina Ronacher
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

Review 8.  Regulation and function of proinflammatory TH17 cells.

Authors:  Gustavo J Martinez; Roza I Nurieva; Xuexian O Yang; Chen Dong
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression.

Authors:  Rohan Dhiman; Sambasivan Venkatasubramanian; Padmaja Paidipally; Peter F Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

10.  S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.

Authors:  Radha Gopal; Leticia Monin; Diana Torres; Samantha Slight; Smriti Mehra; Kyle C McKenna; Beth A Fallert Junecko; Todd A Reinhart; Jay Kolls; Renata Báez-Saldaña; Alfredo Cruz-Lagunas; Tatiana S Rodríguez-Reyna; Nathella Pavan Kumar; Phillipe Tessier; Johannes Roth; Moisés Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Bridgette Cumming; Victoria O Kasprowicz; Adrie J C Steyn; Subash Babu; Deepak Kaushal; Joaquín Zúñiga; Thomas Vogl; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.